Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Finance Friday: 28 January 2011

$100 bills in a circle (Photos8.com)

(Photos8.com)

Here are recent angel and venture finance transactions for science- and engineering-based companies reported by Xconomy.

Biomedical/Life Sciences

Meritage Pharma in San Diego, California. Specialty drug discovery and development. $2 million, equity.

XDx in Brisbane, California. Molecular diagnostics. $12.5 million, debt (from GE Capital)

Stromedix in Cambridge, Massachusetts. Specialty drug discovery and development. $2 million, debt.

RainDance Technologies in Lexington, Massachusetts. Genomic research tools. $37.5 million, series D equity.

Energy

Envia Systems in Newark, California. Cathodes for high-capacity lithium ion batteries. $17 million, series C equity.

Fulcrum BioEnergy in Pleasanton, California. Technology for converting municipal solid waste into ethanol. $75 million, series C equity.

Physical Sciences

Myriant Technologies in Quincy, Massachusetts. Biochemicals. $60 million, equity financing (from PTT Chemical Public Company, Thailand)

Xtalic in Marlborough, Massachusetts. Nanostructured alloy coatings for electronics components. $8 million, equity.

Engineering and Electronics

Liquid Piston in Bloomfield, Connecticut. Advanced internal combustion engines. $5 million, series B equity.

Liquid Robotics, in Sunnyvale, California. Maritime robotic vehicles. $18 million, equity.

Read more: Finance Friday: 21 January 2011

*     *     *

2 comments to Finance Friday: 28 January 2011